Activity-dependent MAP6 scaffolding at synapses

Target: MAP6 Composite Score: 0.600 Price: $0.50 Citation Quality: 55% neurodegeneration Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
✓ All Quality Gates Passed
Quality Report Card click to collapse
B
Composite: 0.600
Top 50% of 1402 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
B Mech. Plausibility 15% 0.65 Top 49%
B Evidence Strength 15% 0.60 Top 45%
B Novelty 12% 0.60 Top 74%
B Feasibility 12% 0.60 Top 45%
F Impact 12% 0.00 Top 50%
F Druggability 10% 0.00 Top 50%
F Safety Profile 8% 0.00 Top 50%
F Competition 6% 0.00 Top 50%
F Data Availability 5% 0.00 Top 50%
F Reproducibility 5% 0.00 Top 50%
Evidence
1 supporting | 0 opposing
Citation quality: 0%
Debates
1 session B+
Avg quality: 0.72
Convergence
0.00 F 4 related hypothesis share this target

Hypotheses from Same Analysis (2)

These hypotheses emerged from the same multi-agent debate that produced this hypothesis.

MAP6-CRMPS cooperative phosphorylation by GSK3β
Score: 0.700 | Target: MAP6/CRMP2
MAP6-mediated microtubule stabilization as therapeutic target
Score: 0.500 | Target: MAP6

Description

MAP6 may scaffold signaling complexes at synapses in an activity-dependent manner, linking NMDA receptor activation to cytoskeletal remodeling via its multiple functional domains

Prediction: MAP6 will physically associate with synaptic signaling proteins in a phosphorylation-dependent manner, and LTP-inducing stimulation will recruit MAP6 to dendritic spines

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["MAP6 Occupancy on Microtubules
Cold-Stable Cytoskeletal Support"] B["Tau/MAPT Lattice Competition
Dynamic Binding Balance"] C["Synaptic Remodeling Signals
NMDA-Linked Cytoskeletal Plasticity"] D["Axonal Transport and Branching
Circuit Adaptation"] E["MAP6-Tau Imbalance
Rigid or Unstable Cytoskeleton"] A --> B B --> C C --> D E -.->|"disrupts"| B style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7 style D fill:#1b5e20,stroke:#81c784,color:#81c784 style E fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

3D Protein Structure (AlphaFold)

Open full viewer

AlphaFold predicted structure available for Q96JE9

View AlphaFold Structure

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.65 (15%) Evidence 0.60 (15%) Novelty 0.60 (12%) Feasibility 0.60 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.600 composite
1 citations 0 with PMID Validation: 0% 1 supporting / 0 opposing
For (1)
No supporting evidence
No opposing evidence
(0) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
1
MECH 1CLIN 0GENE 0EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
MAP6 may scaffold signaling complexes at synapses …SupportingMECH------
Legacy Card View — expandable citation cards

Supporting Evidence 1

MAP6 may scaffold signaling complexes at synapses in an activity-dependent manner, linking NMDA receptor activ…
MAP6 may scaffold signaling complexes at synapses in an activity-dependent manner, linking NMDA receptor activation to cytoskeletal remodeling via its multiple functional domains

Opposing Evidence 0

No evidence recorded
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Artifact Review | 4 rounds | 2026-04-25 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Theoretical Evaluation: MAP6 and CRMPs in Neuronal Function and Neurodegeneration

1. Key Scientific Contributions

1.1 Unification of MAP6's Pleiotropic Functions Under a Single Conceptual Framework


This review synthesizes two decades of work demonstrating that MAP6 (STOP) is far more than a microtubule stabilizer. The authors establish MAP6 as a signaling scaffold that coordinates microtubule dynamics, actin cytoskeleton remodeling, and receptor trafficking. This reframing is significant because it positions MAP6 as a potential integrator of cytoskeletal responses to neuronal ac

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation: MAP6 and CRMPs Review Article

1. Key Methodological Weaknesses

1.1 Literature Synthesis Lacks Systematic Rigor


This is a narrative review, not a systematic review. The authors present their interpretation of "extensive data obtained over 20 years" without transparent inclusion/exclusion criteria for studies. This introduces selection bias—the review naturally emphasizes work from the authors' own laboratory (Grenoble Institut Neurosciences) while potentially underrepresenting conflicting findings. A cursory PubMed search reveals that several key authors appe

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Expert Assessment: MAP6 and CRMPs Review Article (PMID: 34025352)

1. Novelty Rating: 6/10

This review provides moderate conceptual novelty within the broader MAP/c cytoskeleton field.

Strengths:

  • First comprehensive synthesis linking MAP6 to such a diverse array of neuronal functions
  • The MAP6-CRMPS convergence framework is genuinely informative, as these protein families have been studied largely in parallel
  • The "beyond stabilization" framing articulates an important shift in thinking about MAPs generally
Limitations:
  • As a narrative review, novelty is constrained by

Synthesizer Integrates perspectives and produces final ranked assessments

{"summary":"This 2021 review from the Grenoble research group synthesizes two decades of research on MAP6 (STOP), repositioning it from a simple microtubule stabilizer to a multifunctional signaling scaffold that coordinates cytoskeletal dynamics, actin remodeling, and receptor trafficking. The authors articulate a convergence framework linking MAP6 to the CRMP family (collapsin response mediator proteins), highlighting shared roles in semaphorin signaling, axon guidance, and GSK3β-mediated phosphorylation. The review extends MAP6 function beyond microtubule binding to encompass synaptic plast

Price History

0.590.600.61 0.62 0.58 2026-04-252026-04-252026-04-25 Market PriceScoreevidencedebate 1 events
7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
1

Clinical Trials (0) Relevance: 70%

No clinical trials data available

📚 Cited Papers (0)

No linked papers yet

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

📓 Linked Notebooks (0)

No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
31.7th percentile (747 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
0

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.650

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

Related Hypotheses

Tau/MAP6 antagonism in neurodegeneration progression
Score: 0.650 | neurodegeneration
Domain boundary cross-talk hypothesis
Score: 0.600 | neurodegeneration
Tau-Independent Microtubule Stabilization via MAP6 Enhancement
Score: 0.567 | neurodegeneration
MAP6-mediated microtubule stabilization as therapeutic target
Score: 0.500 | neurodegeneration

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (0 edges)

No knowledge graph edges recorded

Predicted Protein Structure

🔮 MAP6 — AlphaFold Prediction Q96JE9 Click to expand 3D viewer

AI-predicted structure from AlphaFold | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)